帕司烟肼(pasiniazide,1)又名百生肼、对氨基水杨酸异烟肼,为对氨基水杨酸(2)与异烟肼(3)的化学加合物,化学名为4-吡啶甲酰肼-4-氨基水杨酸。它由瑞士Geistlich Pharma AG研发,于2001年上市,是一种强效抗结核病药物,药效比3强5倍。该药品中2能有效地延缓和阻滞3在体内的乙酰化过程,使血液中的3能在较高浓度水平上维持较长 Pasiniazide (1), also known as luteolin, isoniazid p-aminosalicylate, is a chemical adduct of p-aminosalicylic acid (2) and isoniazid (3) -picolinic acid hydrazide-4-aminosalicylic acid. Developed by Geistlich Pharma AG in Switzerland and marketed in 2001, it is a potent anti-tuberculosis drug with 5 times more potent potency than 3. 2 in the drug can effectively delay and retard the 3 acetylation in the body so that 3 in the blood can be maintained at a higher concentration level longer